NICE recommends evidence-based interventions including lifestyle modification (diet, physical activity, behavioural strategies), licensed medications such as orlistat, semaglutide, and liraglutide for appropriate patients in specialist services, and bariatric surgery for severe obesity with comorbidities
Because GLP-1 medications suppress appetite, combining them with a ketogenic diet can increase the risk of undereating, since ketogenic approaches may further reduce hunger
Physical activity regulation supports overall treatment success
Diabetes Obes Metab 2008;10:931-938
Heres who might benefit the most from this medication: 1
The FAA requires documentation that the medication causes no disqualifying effects on judgment, coordination, or reaction time